🧵on Morepen Labs💉
- an India-based pharmaceutical company (2500 cr mkt cap) with following pdt portfolio:
①API Business
②Formulations
③Medical Devices
④OTC
Disc: Invested for short-term, intent of thread is to share info not a recommendation to buy.👇⏬
1/13
- an India-based pharmaceutical company (2500 cr mkt cap) with following pdt portfolio:
①API Business
②Formulations
③Medical Devices
④OTC
Disc: Invested for short-term, intent of thread is to share info not a recommendation to buy.👇⏬
1/13
2/ Started by Mr. K B Suri as API Company, before I write good things, let me share with "Legacy Issues" and "Management Response" to these Legacy Issues.
⏬
⏬
3/ Legacy Issues - y market is negative about its past 👇
1. SEBI Ban
2. Delays in making payments in ESI, EPF & Taxes
3. Promoter Salary
4. Ongoing case on appointing Govt Director
5. Cancellation of shares allotted to FD holders
6. Warrants issued to promoters
Source: Internet
1. SEBI Ban
2. Delays in making payments in ESI, EPF & Taxes
3. Promoter Salary
4. Ongoing case on appointing Govt Director
5. Cancellation of shares allotted to FD holders
6. Warrants issued to promoters
Source: Internet
4/ CMD Sushil Suri response to Legacy Issues:
Starts at 12.00 min
Starts at 12.00 min
5/ How was 2021 for Morepen:
1. API grew by 44%
2. Diagnostics by 71% (of course Covid impact)
3. Formulations by -5%
4. OTC - 32%
Business Breakup
1. API - 62%
2. Diagnostic Devices - 26.1%
3. Formulations - 11.9%
1. API grew by 44%
2. Diagnostics by 71% (of course Covid impact)
3. Formulations by -5%
4. OTC - 32%
Business Breakup
1. API - 62%
2. Diagnostic Devices - 26.1%
3. Formulations - 11.9%
6/ Insight into their businesses in terms of growth since 2018
1. API rev & export grew at 26% CAGR
2. Medical Devices grew at 41% CAGR
3. Formulations by -5% CAGR
4. OTC rev grew by 20% CAGR
1. API rev & export grew at 26% CAGR
2. Medical Devices grew at 41% CAGR
3. Formulations by -5% CAGR
4. OTC rev grew by 20% CAGR
7/ Expansion Plans
Product Development Investments @ Morepen Labs:
1. Health & Fitness
2. Nutraceuticals
3. Energy Drinks & Capsules
4. Ayurveda
5. Cosmetology
6. Packaging Innovations
Product Development Investments @ Morepen Labs:
1. Health & Fitness
2. Nutraceuticals
3. Energy Drinks & Capsules
4. Ayurveda
5. Cosmetology
6. Packaging Innovations
8/ Expansion Plans
Capitalising on the equity of Dr Morepen:
1. OTC Trade - 100 pdts (500 pdts in 3 yrs)
2. Online Health & Nutrition (1000 pdts in 3 yrs)
3. Grooming - 200 pds available (500 pdts in 3 yrs)
Capitalising on the equity of Dr Morepen:
1. OTC Trade - 100 pdts (500 pdts in 3 yrs)
2. Online Health & Nutrition (1000 pdts in 3 yrs)
3. Grooming - 200 pds available (500 pdts in 3 yrs)
9/ Dr Morepen OTC, Health & Nutrition👇
10/ Morepen's few key milestones
1992 -IPO
2000 -stock hit ATH of Rs 840 (Tie-up with Diamed AG Switzerland could be the trigger)
2001 -Acquired Burnol Brand
2020 -ISO Certification for medical devices
2021 -750 crore investment secured from Corinth Group, Switzerland
Infra👇
1992 -IPO
2000 -stock hit ATH of Rs 840 (Tie-up with Diamed AG Switzerland could be the trigger)
2001 -Acquired Burnol Brand
2020 -ISO Certification for medical devices
2021 -750 crore investment secured from Corinth Group, Switzerland
Infra👇
11/ To know more about Indian Pharma Industry & Indian Govt's PLI Scheme, please read here👇
https://twitter.com/Kiran24Rajput/status/1396129342854336512?s=20
12/ To know more why the share price fell from Rs 840 to single digit, please listen to CMD - 12:30 onwards👇
13/ Ratios & Financials👇
• • •
Missing some Tweet in this thread? You can try to
force a refresh
